GSK spinoff Haleon starts trading in largest European listing in a decade


Europe’s biggest listing in a decade, Haleon, started trading on the London Stock Exchange on Monday. Haleon in the consumer-health business spinoff of GSK GSK, -0.30%. The combined price of Haleon, 331.7 pence, and the remaining GSK, 1,383.40 pence, of 1715.10 pence, compares to GSK’s Friday close of 1,719.20 pence. Haleon will start trading on a when-issued basis on the New York Stock Exchange on Monday, with full trading slated for Friday.

This article was originally published by Read the original article here.

Previous article: ‘They’ve owned these pets for years’: People are giving up family dogs they adopted long before the pandemic, mostly due to inflation, shelters say
Next articleBank of America shares drop nearly 2% as earnings, revenue shy of consensus


Please enter your comment!
Please enter your name here